Lentiviral vectors: their molecular design, safety, and use in laboratory and preclinical research

Boro Dropulić1

  • 1Lentigen Corporation, Gaithersburg, MD 20878, USA. boro.dropulic@Lentigen.com

Human Gene Therapy
|April 14, 2011
PubMed

Related Concept Videos